Asthma Clinical Trials in Chicago

Showing 321-340 of 427 trials

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

NCT00829985

There is currently no effective way to prevent development of allergic rhinitis (nasal allergies) and asthma and no cure. Sublingual immunotherapy (SLIT), a type of therapy in which allergens are placed under the tongue, may be a way to control and possibly prevent allergic rhinitis and asthma. However, detailed research of this approach is limited. The purpose of this study is to evaluate the safety and efficacy of a sublingual cockroach extract given to adults with perennial allergic rhinitis, asthma, or both.

Rhinitis, Allergic, PerennialAsthma

National Institute of Allergy and Infectious Diseases (NIAID)54 participantsStarted Jan 2009

Denver, Colorado, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +1 more locations

COMPLETED2.2 miles

Asthma Phenotypes in the Inner City

NCT01383941

This is an epidemiologic, multi-center, cross-sectional study to define the phenotypic characteristics of Difficult-to-Treat asthma, among children between the ages of 6 to 17 years, receiving one year of guidelines-based therapy for asthma and rhinitis/rhinosinusitis.

AsthmaRhinitis

National Institute of Allergy and Infectious Diseases (NIAID)717 participantsStarted Aug 2011

Denver, Colorado, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +6 more locations

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

Asthma Phenotypes in the Inner City

Asthma Trials in Other Cities

Individualized Therapy For Asthma in Toddlers

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents

Study Of Asthma In Patients Of African Descent

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

Drug Study of Albuterol to Treat Acute Lung Injury

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

Efficacy and Safety Study in Subjects With Asthma

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Other Conditions in Chicago